MAKO Surgical Securities Fraud Lawsuit Deadline Approaching. Gilman Law LLP Encourages MAKO Investors with Losses in Excess of $300,000 to Inquire About the Lead Plaintiff Position.
05/17 07:30 AM
--------------------------------------------------------------------------------
NAPLES, Fla.--(BUSINESS WIRE)-- The Leading National Securities Law Firm Gilman Law LLP announces that a MAKO Surgical Securities Fraud Lawsuit has commenced in the United States District Court for the Southern District of Florida against MAKO Surgical Corp. (MAKO:$23.00,00$0.93,004.21%) (Case 12-60875) (NASDAQ:MAKO). The lawsuit alleges that MAKO Surgical (MAKO:$23.00,00$0.93,004.21%) and its executives issued materially false and misleading statements to MAKO investors as well as omitted pertinent information, thereby violating the Securities Exchange Act of 1934.
If you purchased or otherwise acquired shares of MAKO Surgical (MAKO:$23.00,00$0.93,004.21%) common stock between January 9, 2012, and May 7, 2012, (the “class period”), you are encouraged to contact Gilman Law before the July 9, 2012 Deadline. MAKO Shareholders may inquire about the MAKO Securities Fraud Lawsuit as follows:
Deadline:
July 9, 2012
Contact:
Tom Shea, Gilman Law LLP
Telephone:
(239) 221-8301
E-mail:
consultations@gilmanlawllp.com
Website:
MAKO Surgical Securities Fraud Lawsuit
Current shareholders of MAKO common stock and current or former employees of MAKO Surgical (MAKO:$23.00,00$0.93,004.21%) may have additional claims.
MAKO Securities Fraud Lawsuit Details
MAKO Surgical (MAKO:$23.00,00$0.93,004.21%) manufactures advanced robotic arm solution and orthopedic implants for orthopedic procedures. The Company’s RIO Robotic Arm Interactive Orthopedic (“RIO”) system and MAKOplasty applications helps orthopedic surgeons treat patient specific osteoarthritic disease. The Complaint alleges that the Company and certain of its executive officers misrepresented or failed to disclose material information to its shareholders. MAKO reported on Monday, May 7, 2012 that its revenue increased 51%, year over year in its first quarter. However, according to the Complaint, “the Company was poised to suffer a wider first quarter loss as it was experiencing higher costs and slower sales of its RIO systems.”
About Our Investment Losses and Securities Fraud Law Firm
The experienced investment losses and securities fraud attorneys of Gilman Law LLP have over 33 years of experience in securities law and have been involved in all major aspects of securities litigation. Our securities lawyers focus on cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.
Follow Us: Twitter | Facebook | Google+ | LinkedIn | Securities Blog
Source: Gilman Law LLP
Market Data 
Markets 
AI
